EmpiraMed Acquired by StoryCatch Partners to Advance Real-World Evidence Initiatives
Deal News | Nov 20, 2024 | Globenewswire
StoryCatch Partners, a Public Benefit Corporation dedicated to enhancing mental and physical wellbeing through storytelling, has announced its acquisition of EmpiraMed Inc. EmpiraMed is renowned for its pioneering work in virtual clinical studies and real-world evidence gathering through site-less research methods. With this acquisition, StoryCatch intends to integrate EmpiraMed’s expertise in decentralized clinical trials and real-world evidence to better understand and address mental, emotional, and physical health issues. This alignment enhances StoryCatch’s mission of delivering empathy-driven and evidence-based support for complex health challenges. The acquisition will see EmpiraMed's team remain intact, while industry veteran James Cavan will lead the transition under the ongoing leadership of StoryCatch CEO Samantha Burman Trotman.
Sectors
- Digital Health Technology
- Clinical Trials
- Public Benefit Corporation
Geography
- United States – Both StoryCatch Partners and EmpiraMed are based in Massachusetts, USA, which is central to the acquisition.
Industry
- Digital Health Technology – The article discusses StoryCatch Partners acquiring EmpiraMed, a digital health company known for virtual clinical studies and real-world evidence.
- Clinical Trials – EmpiraMed specializes in decentralized clinical trials to gather real-world evidence, forming a core part of the acquisition's strategic goals.
- Public Benefit Corporation – StoryCatch Partners is structured as a Public Benefit Corporation with a focus on improving mental and physical wellbeing.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| StoryCatch Partners | Acquirer | Company | A Public Benefit Corporation focused on improving mental and physical wellbeing through storytelling. |
| EmpiraMed Inc. | Target Company | Company | A digital health technology leader known for pioneering virtual clinical studies to generate real-world evidence. |
| Keith Parent | Founder of EmpiraMed | Person | Founder of EmpiraMed, emphasizing patient engagement in data self-reporting for studies. |
| Samantha Burman Trotman | CEO of StoryCatch Partners | Person | Co-founder and CEO of StoryCatch Partners, with a background in leadership and investment. |
| James Cavan | Transition Leader for EmpiraMed | Person | Industry veteran who will lead EmpiraMed during the transition post-acquisition. |